PEAR

Pear Therapeutics, Inc. Class A Common Stock
PEAR

Delisted

PEAR was delisted on the 18th of April, 2023.

Back to rankings

18 hedge funds and large institutions have $26.9M invested in Pear Therapeutics, Inc. Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.87M
2
+$6.38M
3
+$2.4M
4
OCM
Oribel Capital Management
New York
+$2.05M
5
SC
Sculptor Capital
New York
+$1.93M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.87M
2
$6.38M
3
$2.4M
4
$2.05M
5
$1.93M
6
$1.74M
7
$1.45M
8
$959K
9
$676K
10
$482K
11
$480K
12
$382K
13
$241K
14
$240K
15
$240K
16
$240K
17
$121K
18
$1K